S. Kim

Sung-Bae Kim, C. Suh, M. Ryu, 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Interim 18F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine

Jong Hoon Kim, J. Huh, C. Suh, 2017, Annals of Hematology.

Advanced POEMS syndrome treated with high-dose melphalan followed by autologous blood stem cell transplantation: a single-center experience

C. Suh, W. Min, Y. Lim, 2014, Blood research.

Prognostic impact of β2-microglobulin in patients with non-gastric mucosa-associated lymphoid tissue lymphoma

Sang‐wook Lee, J. Huh, C. Suh, 2015, Leukemia & lymphoma.

Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma.

C. Kim, J. Huh, C. Suh, 2012, American journal of clinical pathology.

ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.2.128 Clinicopathologic Characteristics of T-cell Non-Hodgkin’s Lymphoma: A Single Institution Experience

Dae-Ho Lee, J. Huh, C. Suh, 2022 .

Blastic plasmacytoid dendritic cell neoplasm: a single-center experience

Su-Jin Shin, J. Huh, C. Suh, 2013, Annals of Hematology.

Rituximab‐ESHAP as a mobilization regimen for relapsed or refractory B‐cell lymphomas: a comparison with ESHAP

Sung Sook Lee, Dae-Ho Lee, J. Huh, 2007, Transfusion.

VPDL Chemotherapy for T-cell Lymphoblastic Lymphoma (T-LBL) in Adults: Comparison with Upfront Autologous Stem Cell Transplantation in a Single Center

Dae-Ho Lee, J. Huh, C. Suh, 2008 .

Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis

C. Suh, D. Yoon, Ji Sung Lee, 2019, Transfusion.

Prospective randomized comparative observation of single- vs split-dose lenograstim to mobilize peripheral blood progenitor cells following chemotherapy in patients with multiple myeloma or non-Hodgkin’s lymphoma

J. Huh, C. Suh, H. Chi, 2005, Annals of Hematology.

ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF

S. Kim, J. Huh, C. Suh, 2005, Bone Marrow Transplantation.

Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000

C. Suh, K. Park, H. Chi, 2004, Transfusion.

Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study

M. S. Lee, J. S. Lee, M. Yi, 1999, British Journal of Cancer.

A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomas

Jinny Park, J. H. Lee, Dae-Ho Lee, 2012, The Korean journal of hematology.

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival

Dae-Ho Lee, J. Huh, C. Suh, 2007, Annals of Hematology.

A prognostic index for extranodal marginal‐zone lymphoma based on the mucosa‐associated lymphoid tissue International Prognostic Index and serum β2‐microglobulin levels

Sang‐wook Lee, J. Huh, C. Suh, 2020, British journal of haematology.

Serum beta‐2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma

Sang‐wook Lee, J. Huh, C. Suh, 2016, Hematological oncology.

Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial

J. Ahn, S. Rha, H. Jeung, 2021, ESMO open.

The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma

Sang‐wook Lee, Dae-Ho Lee, J. Huh, 2012, Annals of Hematology.

Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma

Sang-We Kim, Dae-Ho Lee, C. Suh, 2011, Investigational New Drugs.

New staging systems can predict prognosis of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation as first-line therapy.

J. H. Lee, Kihyun Kim, C. Suh, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Real-world Experience of Improvement in the Survival of Lymphoma and Myeloma Patients with Autologous Stem Cell Transplantation over a 25-year Period

C. Suh, Hyungwoo Cho, S. Kim, 2021, The Korean Journal of Medicine.

Single-Center Real-World Experience of Multiple Myeloma in the 21st Century

C. Suh, Hyungwoo Cho, S. Kim, 2022, The Korean Journal of Medicine.

Increment of hematopoietic progenitor cell count as an indicator of efficient autologs stem cell harvest in patients with multiple myeloma

Sang‐wook Lee, J. Huh, C. Suh, 2012, Journal of clinical apheresis.

Low‐dose lenograstim to enhance engraftment after autologous stem cell transplantation: a prospective randomized evaluation of two different fixed doses

Sung-Bae Kim, Kihyun Kim, C. Suh, 2004, Transfusion.

Remobilization of hematopoietic stem cells with high‐dose methotrexate and cytarabine in patients with non‐Hodgkin's lymphoma and multiple myeloma after failure to mobilize with chemotherapy and cytokines

J. Huh, C. Suh, D. Yoon, 2014, Transfusion.

18F-FDG PET in Patients with Primary Systemic Anaplastic Large Cell Lymphoma: Differential Features According to Expression of Anaplastic Lymphoma Kinase

J. Huh, C. Suh, J. Ryu, 2013, Nuclear Medicine and Molecular Imaging.